Title:
BENZAMIDE COMPOUNDS
Document Type and Number:
WIPO Patent Application WO/2019/139900
Kind Code:
A1
Abstract:
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.
More Like This:
| JP2022008530 | MATERIALS FOR ELECTRONIC DEVICES |
| WO/2003/099816 | IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS |
| JP2023109932 | TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE |
Inventors:
PINCHMAN JOSEPH (US)
HUANG PETER (US)
BUNKER KEVIN (US)
SIT RAKESH (US)
SAMATAR AHMED (US)
HUANG PETER (US)
BUNKER KEVIN (US)
SIT RAKESH (US)
SAMATAR AHMED (US)
Application Number:
PCT/US2019/012699
Publication Date:
July 18, 2019
Filing Date:
January 08, 2019
Export Citation:
Assignee:
ZENO ROYALTIES & MILESTONES LLC (US)
International Classes:
C07D471/04; A61K31/407; A61K31/437; A61K31/496; A61K31/5377; A61P31/18; A61P35/00; C07D211/46; C07D295/155; C07D471/14; C07D491/107
Domestic Patent References:
| WO2005049593A2 | 2005-06-02 | |||
| WO2016172194A1 | 2016-10-27 |
Other References:
SHIPRA, G. ET AL.: "Identification of Novel Potent Inhibitors Against Bcl-xL Anti- apoptotic Protein Using Docking Studies", PROTEIN & PEPTIDE LETTERS, vol. 19, no. 12, October 2012 (2012-10-01), pages 1302 - 1317, XP055625678
BRUNCKO, M. ET AL.: "Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL", JOURNAL OF MEDICINAL CHEMISTRY, vol. 50, no. 4, January 2007 (2007-01-01), pages 641 - 662, XP002661692
BRUNCKO, M. ET AL.: "Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL", JOURNAL OF MEDICINAL CHEMISTRY, vol. 50, no. 4, January 2007 (2007-01-01), pages 641 - 662, XP002661692
Attorney, Agent or Firm:
MALLON, Joseph, J. (US)
Download PDF:
Previous Patent: BENZAMIDE COMPOUNDS
Next Patent: NASAL EXOSOMES FOR NON-INVASIVE SAMPLING OF CNS PROTEINS
Next Patent: NASAL EXOSOMES FOR NON-INVASIVE SAMPLING OF CNS PROTEINS